Ligand validation:1AGN

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1AGN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1AGN_NAD_D_377	70%	7%	0.147	0.966	2.57	2.2	10	13	8	0	100%	1
1AGN_NAD_C_377	66%	9%	0.135	0.941	2.67	1.83	8	9	3	0	100%	1
1AGN_NAD_B_377	65%	9%	0.147	0.949	2.48	2.04	11	10	2	0	100%	1
1AGN_NAD_A_377	57%	13%	0.19	0.968	2.02	1.91	10	15	2	0	100%	1
1D1S_NAD_D_4377	84%	11%	0.112	0.974	2.13	2.05	8	9	2	0	100%	1
1D1T_NAD_A_1377	79%	13%	0.124	0.969	1.91	2.03	8	11	2	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.